|
Committee News The House Committee on Energy and Commerce |
|
|
Tauzin Delivers Statement on Medical Privacy
WASHINGTON
(March 22) – Rep. Billy Tauzin
(R-LA), Chairman of the Committee on Energy and Commerce, today is scheduled to
deliver the following remarks at a Health Subcommittee hearing on Federal
medical record privacy regulation: “Let me begin by thanking
Subcommittee Chairman Bilirakis for holding this timely hearing on the Federal
medical record privacy regulation, which is now the subject of a comment period
that expires at the end of the month. “The Energy and Commerce
Committee has already held two hearings this year on privacy.
This hearing, of course, will focus on medical privacy, an area of the
law that raises a host of important issues for consumers and health care
providers. “The specific purpose of this
hearing today will be to examine a regulation that was issued in the closing
days of the Clinton Administration. Once
the new Administration has time to review the comments they are receiving on
this regulation, we will bring Secretary Thompson’s team forward and hear
their thoughts about how the regulation can be improved.
As I told my good friend Mr. Dingell this week, we are working to arrange
a time to host Secretary Thompson or his designee at a hearing before this
Committee so that we can inquire further into their positions on this privacy
regulation. “We all want to be sure that
our medical records are kept private, and this is not a new concern.
In fact, the Hippocratic Oath states that ‘Whatever, in connection with
my professional service, or not in connection with it, I see or hear, in the
life of men, which ought not to be spoken of abroad, I will not divulge, as
reckoning that all such should be kept secret.’
Physicians have subscribed to these tenets since at least the 4th
Century B.C., and these principles still apply today. “Unfortunately, in the
interconnected 21st Century, relying on the Hippocratic Oath isn’t
good enough. Records are reduced to
electronic form and shipped from one part of the country to another for
diagnosis, payment, fulfilling prescriptions, or epidemiological research.
Every “And that’s why we are here
today—to discuss these issues. During
this hearing, we want to examine the implications of moving forward with the
Clinton Administration’s privacy policy.
While we have no doubt that drafting this regulation was an arduous
process, and an unenviable task, we still need to explore how we can improve
this regulation and make it work more effectively for consumers and health care
providers.
“We all want today’s
hearing to be constructive. For
example, I hope that we can hear about what parts of the regulation could be
strengthened from a consumer’s point of view.
How can we better draft this regulation to bring these new protections to
consumers in a more cost-effective way? What
provisions need a little more fine-tuning in light of real-life practices?
These are the kinds of issues we would like to explore today.” ####
|
|